Viewing Study NCT05059106


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-04-20 @ 6:36 PM
Study NCT ID: NCT05059106
Status: UNKNOWN
Last Update Posted: 2021-09-28
First Post: 2021-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
Sponsor: Federal University of Espirito Santo
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: FUES02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER_GOV View
None UNKNOWN View
None OTHER View
None UNKNOWN View